Status:
COMPLETED
Database Surveillance Safety Study of PENTACEL® Vaccine
Lead Sponsor:
Sanofi Pasteur, a Sanofi Company
Conditions:
Diphtheria
Tetanus
Eligibility:
MALE
6-24 years
Brief Summary
The objective for this study is to characterize the safety profile of PENTACEL® vaccine for identification of potential vaccine-related adverse events not currently associated with PENTACEL® vaccine a...
Detailed Description
The study will be conducted at Kaiser Permanente Northern California and will commence with first use of licensed PENTACEL® vaccine within that organization. Vaccination databases will be reviewed to...
Eligibility Criteria
Inclusion
- Receipt of DTaP vaccine during the study period by a previously unvaccinated child
Exclusion
- None
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
62538 Patients enrolled
Trial Details
Trial ID
NCT00804284
Start Date
September 1 2008
End Date
January 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oakland, California, United States, 94612